Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

CYAD

Celyad Oncology (CYAD)

Celyad Oncology SA
Date:
Sort by:
 Showing the most relevant articles for your search:EU:CYAD
DateTimeSourceHeadlineSymbolCompany
02/08/20244:01PMGlobeNewswire Inc.Celyad Oncology announces intention to terminate SEC reporting obligationsEU:CYADCelyad Oncology SA
01/16/20244:01PMGlobeNewswire Inc.Celyad Oncology provides fourth quarter 2023 business update and 2024 outlookEU:CYADCelyad Oncology SA
12/20/20234:01PMGlobeNewswire Inc.Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)EU:CYADCelyad Oncology SA
12/15/20234:01PMGlobeNewswire Inc.Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)EU:CYADCelyad Oncology SA
12/04/20234:01PMGlobeNewswire Inc.Celyad announces management changeEU:CYADCelyad Oncology SA
12/01/20236:42AMGlobeNewswire Inc.Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)EU:CYADCelyad Oncology SA
11/21/20234:00PMGlobeNewswire Inc.Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)EU:CYADCelyad Oncology SA
11/14/20234:00PMGlobeNewswire Inc.Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)EU:CYADCelyad Oncology SA
11/09/20231:00AMGlobeNewswire Inc.Celyad Oncology reports third quarter 2023 financial results and recent business highlightsEU:CYADCelyad Oncology SA
09/25/20234:01PMGlobeNewswire Inc.Celyad Oncology announces the termination of its American Depository Receipt programEU:CYADCelyad Oncology SA
09/15/20234:01PMGlobeNewswire Inc.Publication of a rectified transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)EU:CYADCelyad Oncology SA
09/12/20234:01PMGlobeNewswire Inc.Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)EU:CYADCelyad Oncology SA
09/07/20234:01PMGlobeNewswire Inc.Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)EU:CYADCelyad Oncology SA
09/05/20234:00PMGlobeNewswire Inc.Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)EU:CYADCelyad Oncology SA
09/04/20234:00PMGlobeNewswire Inc.Celyad Oncology Reports First Half 2023 Financial Results and Recent Business HighlightsEU:CYADCelyad Oncology SA
08/24/20234:00PMGlobeNewswire Inc.Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical shareholdersEU:CYADCelyad Oncology SA
05/15/20234:01PMGlobeNewswire Inc.Celyad Oncology announces receipt of Nasdaq delisting noticeEU:CYADCelyad Oncology SA
05/05/20231:00AMGlobeNewswire Inc.Celyad Oncology Announces Intent to Voluntarily Delist American Depository Shares From NasdaqEU:CYADCelyad Oncology SA
05/05/20231:00AMGlobeNewswire Inc.Celyad Oncology reports first quarter 2023 financial results and recent business highlightsEU:CYADCelyad Oncology SA
04/24/20234:01PMGlobeNewswire Inc.Celyad Oncology announces receipt of Nasdaq initial notification on ADS bid priceEU:CYADCelyad Oncology SA
04/04/20234:01PMGlobeNewswire Inc.Celyad Oncology announces receipt of Nasdaq noticeEU:CYADCelyad Oncology SA
03/24/20232:00AMGlobeNewswire Inc.Celyad Oncology appoints Georges Rawadi as its new CEOEU:CYADCelyad Oncology SA
03/23/20235:01PMGlobeNewswire Inc.Celyad Oncology reports full year 2022 financial results and recent business highlightsEU:CYADCelyad Oncology SA
03/17/20235:01PMGlobeNewswire Inc.Celyad Oncology to announce full year 2022 financial results and host conference callEU:CYADCelyad Oncology SA
03/15/20232:00AMGlobeNewswire Inc.Celyad Oncology announces non-cash impairmentEU:CYADCelyad Oncology SA
03/01/20231:00AMGlobeNewswire Inc.REPEAT -- Celyad Oncology SA - Letter to ShareholdersEU:CYADCelyad Oncology SA
02/28/202311:16AMGlobeNewswire Inc.Celyad Oncology SA - Letter to ShareholdersEU:CYADCelyad Oncology SA
02/09/20231:00AMGlobeNewswire Inc.Celyad Oncology announces the publication of data from its Phase 1 THINK study of CYAD-01EU:CYADCelyad Oncology SA
02/03/20231:00AMGlobeNewswire Inc.Celyad Oncology provides fourth quarter 2022 business update and 2023 outlookEU:CYADCelyad Oncology SA
12/21/20221:00AMGlobeNewswire Inc.Celyad Oncology provides an update on its strategic business model, continuing to focus on opportunities to fully harness the true potential of its proprietary technology platforms and intellectual propertyEU:CYADCelyad Oncology SA
 Showing the most relevant articles for your search:EU:CYAD